3-bromopyrrolidin-2-one;(14S)-8-chloro-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one;3,3-dimethylbutan-1-ol;tris((14S)-8-[3-(3,3-dimethylbutoxy)-2-oxopyrrolidin-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one);3-(3,3-dimethylbutoxy)pyrrolidin-2-one

C130H189BrClN25O22S4 — CID 160562655

IUPAC3-bromopyrrolidin-2-one;(14S)-8-chloro-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one;3,3-dimethylbutan-1-ol;tris((14S)-8-[3-(3,3-dimethylbutoxy)-2-oxopyrrolidin-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one);3-(3,3-dimethylbutoxy)pyrrolidin-2-one
SMILESCC(C)(C)CCO.CC(C)(C)CCOC1CCN(c2ccc3c(n2)N2C[C@@H](CCCNc4cccc(n4)S(=O)(=O)NC3=O)CC2(C)C)C1=O.CC(C)(C)CCOC1CCN(c2ccc3c(n2)N2C[C@@H](CCCNc4cccc(n4)S(=O)(=O)NC3=O)CC2(C)C)C1=O.CC(C)(C)CCOC1CCN(c2ccc3c(n2)N2C[C@@H](CCCNc4cccc(n4)S(=O)(=O)NC3=O)CC2(C)C)C1=O.CC(C)(C)CCOC1CCNC1=O.CC1(C)C[C@@H]2CCCNc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(Cl)nc3N1C2.O=C1NCCC1Br
InChIInChI=1S/3C30H42N6O5S.C20H24ClN5O3S.C10H19NO2.C6H14O.C4H6BrNO/c3*1-29(2,3)14-17-41-22-13-16-35(28(22)38)24-12-11-21-26(33-24)36-19-20(18-30(36,4)5)8-7-15-31-23-9-6-10-25(32-23)42(39,40)34-27(21)37;1-20(2)11-13-5-4-10-22-16-6-3-7-17(24-16)30(28,29)25-19(27)14-8-9-15(21)23-18(14)26(20)12-13;1-10(2,3)5-7-13-8-4-6-11-9(8)12;1-6(2,3)4-5-7;5-3-1-2-6-4(3)7/h3*6,9-12,20,22H,7-8,13-19H2,1-5H3,(H,31,32)(H,34,37);3,6-9,13H,4-5,10-12H2,1-2H3,(H,22,24)(H,25,27);8H,4-7H2,1-3H3,(H,11,12);7H,4-5H2,1-3H3;3H,1-2H2,(H,6,7)/t3*20-,22?;13-;;;/m0000.../s1
InChIKeyQZNDDQZQUBRNEU-RRJFOIMWSA-N
MW2697.72 g/mol
LogP17.96
Rot. Bonds16

About 3-bromopyrrolidin-2-one;(14S)-8-chloro-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one;3,3-dimethylbutan-1-ol;tris((14S)-8-[3-(3,3-dimethylbutoxy)-2-oxopyrrolidin-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one);3-(3,3-dimethylbutoxy)pyrrolidin-2-one

3-bromopyrrolidin-2-one;(14S)-8-chloro-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one;3,3-dimethylbutan-1-ol;tris((14S)-8-[3-(3,3-dimethylbutoxy)-2-oxopyrrolidin-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one);3-(3,3-dimethylbutoxy)pyrrolidin-2-one (PubChem CID 160562655) has the molecular formula C130H189BrClN25O22S4 and a molecular weight of 2697.72 g/mol. Its IUPAC name is 3-bromopyrrolidin-2-one;(14S)-8-chloro-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one;3,3-dimethylbutan-1-ol;tris((14S)-8-[3-(3,3-dimethylbutoxy)-2-oxopyrrolidin-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one);3-(3,3-dimethylbutoxy)pyrrolidin-2-one.

Molecular Properties

Compound Name3-bromopyrrolidin-2-one;(14S)-8-chloro-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one;3,3-dimethylbutan-1-ol;tris((14S)-8-[3-(3,3-dimethylbutoxy)-2-oxopyrrolidin-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one);3-(3,3-dimethylbutoxy)pyrrolidin-2-one
PubChem CID160562655
Molecular FormulaC130H189BrClN25O22S4
Molecular Weight2697.72 g/mol
Exact Mass2694.22
IUPAC Name3-bromopyrrolidin-2-one;(14S)-8-chloro-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one;3,3-dimethylbutan-1-ol;tris((14S)-8-[3-(3,3-dimethylbutoxy)-2-oxopyrrolidin-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one);3-(3,3-dimethylbutoxy)pyrrolidin-2-one
SMILESCC(C)(C)CCO.CC(C)(C)CCOC1CCN(c2ccc3c(n2)N2C[C@@H](CCCNc4cccc(n4)S(=O)(=O)NC3=O)CC2(C)C)C1=O.CC(C)(C)CCOC1CCN(c2ccc3c(n2)N2C[C@@H](CCCNc4cccc(n4)S(=O)(=O)NC3=O)CC2(C)C)C1=O.CC(C)(C)CCOC1CCN(c2ccc3c(n2)N2C[C@@H](CCCNc4cccc(n4)S(=O)(=O)NC3=O)CC2(C)C)C1=O.CC(C)(C)CCOC1CCNC1=O.CC1(C)C[C@@H]2CCCNc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(Cl)nc3N1C2.O=C1NCCC1Br
InChIInChI=1S/3C30H42N6O5S.C20H24ClN5O3S.C10H19NO2.C6H14O.C4H6BrNO/c3*1-29(2,3)14-17-41-22-13-16-35(28(22)38)24-12-11-21-26(33-24)36-19-20(18-30(36,4)5)8-7-15-31-23-9-6-10-25(32-23)42(39,40)34-27(21)37;1-20(2)11-13-5-4-10-22-16-6-3-7-17(24-16)30(28,29)25-19(27)14-8-9-15(21)23-18(14)26(20)12-13;1-10(2,3)5-7-13-8-4-6-11-9(8)12;1-6(2,3)4-5-7;5-3-1-2-6-4(3)7/h3*6,9-12,20,22H,7-8,13-19H2,1-5H3,(H,31,32)(H,34,37);3,6-9,13H,4-5,10-12H2,1-2H3,(H,22,24)(H,25,27);8H,4-7H2,1-3H3,(H,11,12);7H,4-5H2,1-3H3;3H,1-2H2,(H,6,7)/t3*20-,22?;13-;;;/m0000.../s1
InChIKeyQZNDDQZQUBRNEU-RRJFOIMWSA-N
XLogP17.96
TPSA593.44 Ų
H-Bond Donors11
H-Bond Acceptors38
Rotatable Bonds16
Heavy Atoms183
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002697.72
LogP ≤ 517.96
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1038

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}

Analyze 3-bromopyrrolidin-2-one;(14S)-8-chloro-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one;3,3-dimethylbutan-1-ol;tris((14S)-8-[3-(3,3-dimethylbutoxy)-2-oxopyrrolidin-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one);3-(3,3-dimethylbutoxy)pyrrolidin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-bromopyrrolidin-2-one;(14S)-8-chloro-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one;3,3-dimethylbutan-1-ol;tris((14S)-8-[3-(3,3-dimethylbutoxy)-2-oxopyrrolidin-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one);3-(3,3-dimethylbutoxy)pyrrolidin-2-one?
The IUPAC name of 3-bromopyrrolidin-2-one;(14S)-8-chloro-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one;3,3-dimethylbutan-1-ol;tris((14S)-8-[3-(3,3-dimethylbutoxy)-2-oxopyrrolidin-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one);3-(3,3-dimethylbutoxy)pyrrolidin-2-one (CID 160562655) is 3-bromopyrrolidin-2-one;(14S)-8-chloro-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one;3,3-dimethylbutan-1-ol;tris((14S)-8-[3-(3,3-dimethylbutoxy)-2-oxopyrrolidin-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one);3-(3,3-dimethylbutoxy)pyrrolidin-2-one.
What is the SMILES notation for 3-bromopyrrolidin-2-one;(14S)-8-chloro-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one;3,3-dimethylbutan-1-ol;tris((14S)-8-[3-(3,3-dimethylbutoxy)-2-oxopyrrolidin-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one);3-(3,3-dimethylbutoxy)pyrrolidin-2-one?
The canonical SMILES for 3-bromopyrrolidin-2-one;(14S)-8-chloro-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one;3,3-dimethylbutan-1-ol;tris((14S)-8-[3-(3,3-dimethylbutoxy)-2-oxopyrrolidin-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one);3-(3,3-dimethylbutoxy)pyrrolidin-2-one is CC(C)(C)CCO.CC(C)(C)CCOC1CCN(c2ccc3c(n2)N2C[C@@H](CCCNc4cccc(n4)S(=O)(=O)NC3=O)CC2(C)C)C1=O.CC(C)(C)CCOC1CCN(c2ccc3c(n2)N2C[C@@H](CCCNc4cccc(n4)S(=O)(=O)NC3=O)CC2(C)C)C1=O.CC(C)(C)CCOC1CCN(c2ccc3c(n2)N2C[C@@H](CCCNc4cccc(n4)S(=O)(=O)NC3=O)CC2(C)C)C1=O.CC(C)(C)CCOC1CCNC1=O.CC1(C)C[C@@H]2CCCNc3cccc(n3)S(=O)(=O)NC(=O)c3ccc(Cl)nc3N1C2.O=C1NCCC1Br.
What is the InChIKey of 3-bromopyrrolidin-2-one;(14S)-8-chloro-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one;3,3-dimethylbutan-1-ol;tris((14S)-8-[3-(3,3-dimethylbutoxy)-2-oxopyrrolidin-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one);3-(3,3-dimethylbutoxy)pyrrolidin-2-one?
The InChIKey is QZNDDQZQUBRNEU-RRJFOIMWSA-N. The full InChI is InChI=1S/3C30H42N6O5S.C20H24ClN5O3S.C10H19NO2.C6H14O.C4H6BrNO/c3*1-29(2,3)14-17-41-22-13-16-35(28(22)38)24-12-11-21-26(33-24)36-19-20(18-30(36,4)5)8-7-15-31-23-9-6-10-25(32-23)42(39,40)34-27(21)37;1-20(2)11-13-5-4-10-22-16-6-3-7-17(24-16)30(28,29)25-19(27)14-8-9-15(21)23-18(14)26(20)12-13;1-10(2,3)5-7-13-8-4-6-11-9(8)12;1-6(2,3)4-5-7;5-3-1-2-6-4(3)7/h3*6,9-12,20,22H,7-8,13-19H2,1-5H3,(H,31,32)(H,34,37);3,6-9,13H,4-5,10-12H2,1-2H3,(H,22,24)(H,25,27);8H,4-7H2,1-3H3,(H,11,12);7H,4-5H2,1-3H3;3H,1-2H2,(H,6,7)/t3*20-,22?;13-;;;/m0000.../s1.
What are the key properties of 3-bromopyrrolidin-2-one;(14S)-8-chloro-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one;3,3-dimethylbutan-1-ol;tris((14S)-8-[3-(3,3-dimethylbutoxy)-2-oxopyrrolidin-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one);3-(3,3-dimethylbutoxy)pyrrolidin-2-one?
3-bromopyrrolidin-2-one;(14S)-8-chloro-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one;3,3-dimethylbutan-1-ol;tris((14S)-8-[3-(3,3-dimethylbutoxy)-2-oxopyrrolidin-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one);3-(3,3-dimethylbutoxy)pyrrolidin-2-one has a molecular weight of 2697.72 g/mol, XLogP of 17.96, 16 rotatable bonds, 11 hydrogen bond donors, and 38 hydrogen bond acceptors.
Where does this data come from?
All data for 3-bromopyrrolidin-2-one;(14S)-8-chloro-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one;3,3-dimethylbutan-1-ol;tris((14S)-8-[3-(3,3-dimethylbutoxy)-2-oxopyrrolidin-1-yl]-12,12-dimethyl-2,2-dioxo-2λ6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one);3-(3,3-dimethylbutoxy)pyrrolidin-2-one is sourced from PubChem (CID 160562655), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).